Table 1.
Potential causes | Diagnostic evaluation patient selection | Potential treatment strategies |
Congenital variants | ||
-PD ± Santorinicele | S-MRCP | ERCP ± EPS at the minor papilla |
± transient dorsal duct stenting | ||
-APBU | S-MRCP | ES |
-Choledochocele | S-MRCP | EBS |
-TypeI& IV choledochal cyst | S-MRCP | Surgical resection + HJ |
-Duodenal duplication cyst | S-MRCP | Endoscopic snare resection |
or surgical resection | ||
-Annular pancreas | S-MRCP | ERCP + EPS |
or surgical gastrojejunostomy | ||
Acquired obstructive conditions | ||
-Suspected neoplasm | ||
ampullary tumor | EUS, S-MRCP | Curative/palliative endotherapy |
MPD stricture | EUS, S-MRCP | or |
IPMT | EUS, S-MRCP | surgery |
-Suspected early CP | EUS, S-MRCP | ERCP + EPS |
± transient MPD stenting | ||
-Groove pancreatitis (CDDW) | EUS, S-MRCP | ERCP + dual ES + MPD stenting |
or surgery or somatostatin | ||
-Pancreatic SOD typeI | ||
Type II | S-MRCP | ERCP + dual ES + transient MPD stenting |
Type III |
PD: Pancreas divisum; APBU: Anomalous pancreaticobiliary union; MPD: Main pancreatic duct; IPMT: Intraductal papillary mucinous tumor; CP: Chronic pancreatitis; CDDW: Cystic dystrophy of the duodenal wall; SOD: Sphincter of Oddi dysfunction; S-MRCP: Secretin-enhanced magnetic resonance cholangiopancreatography; EUS: Endoscopic ultrasonography; ERCP: Endoscopic retrograde cholangiopancreatography; EPS: Endoscopic pancreatic sphincterotomy; ES: Endoscopic sphincterotomy; EBS: Endoscopic biliary sphincterotomy; HJ: Hepaticojejunostomy.